Next Article in Journal
Temporal Change in Alert Override Rate with a Minimally Interruptive Clinical Decision Support on a Next-Generation Electronic Medical Record
Next Article in Special Issue
Ayurveda and Epigenetics
Previous Article in Journal
Human Leukocyte Antigen (HLA) Haplotype Does Not Influence the Inflammatory Pattern of Duodenal Lymphocytosis Linked to Irritable Bowel Syndrome
Previous Article in Special Issue
The Microbiome in Health and Disease from the Perspective of Modern Medicine and Ayurveda
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Ayurgenomics and Modern Medicine

Department of Physiology and Health, Maharishi International University, Fairfield, IA 52556, USA
Medicina 2020, 56(12), 661;
Submission received: 7 October 2020 / Revised: 18 November 2020 / Accepted: 27 November 2020 / Published: 30 November 2020
(This article belongs to the Special Issue The Future of Medicine: Frontiers in Integrative Health and Medicine)


Within the disciplines of modern medicine, P4 medicine is emerging as a new field which focuses on the whole patient. The development of Ayurgenomics could greatly enrich P4 medicine by providing a clear theoretical understanding of the whole patient and a practical application of ancient and modern preventative and therapeutic practices to improve mental and physical health. One of the most difficult challenges today is understanding the ancient concepts of Ayurveda in terms of modern science. To date, a number of researchers have attempted this task, of which one of the most successful outcomes is the creation of the new field of Ayurgenomics. Ayurgenomics integrates concepts in Ayurveda, such as Prakriti, with modern genetics research. It correlates the combination of three doshas, Vata, Pitta and Kapha, with the expression of specific genes and physiological characteristics. It also helps to interpret Ayurveda as an ancient science of epigenetics which assesses the current state of the doshas, and uses specific personalized diet and lifestyle recommendations to improve a patient’s health. This review provides a current update of this emerging field.

1. Introduction

Ayurveda is the ancient system of traditional medicine in India. The term Ayurveda comes from two Sanskrit words, “ayus”, meaning life or lifespan, and “Veda”, meaning knowledge or science. Ayurveda may be translated as “the science of life”, or more specifically, “the science of lifespan”. Ayurveda was originally an oral tradition of natural health, and it was much later that this knowledge was written down in books [1]. Some of the knowledge became fragmented and lost due to many years of foreign rule in India.
The Tridosha theory of Ayurveda explains that there are three fundamental principles or forces, called doshas, which govern the physiology of each individual. Vata is the dosha involved in transportation in the body; from the transportation of molecules to the transportation of nervous impulses. It arises from the elements of ether and air. Pitta is the dosha that governs the process of digestion, as well as all metabolic pathways inside each cell. It is formed from fire and water. Kapha is the dosha that governs structure and cohesion in the body. It is an expression of earth and water. Each individual is born with a particular combination of these three doshas; this is called Prakriti. There are seven basic types of Prakriti: Vata; Pitta; Kapha; Vata/Pitta; Pitta/Kapha; Vata/Kapha; and Vata/Pitta/Kapha.
Is there a scientific explanation for Prakriti? The best description so far has come from the new field of Ayurgenomics, which attempts to describe Prakriti types in terms of modern genetics and physiology.

2. Studies on the Genetic Basis of Prakriti

A number of studies have correlated Prakriti with specific genetic and physiological measures. One early study in 2005 evaluated 76 subjects both for their Prakriti and human leucocyte antigen (HLA) DRB1 types. The researchers observed a correlation between HLA type and Prakriti type, with a complete absence of the HLA DRB1*02 allele in the Vata type and of HLA DRB1*13 in the Kapha type. Furthermore, HLA DRB1*10 had higher allele frequency in the Kapha type compared to the Pitta and Vata types [2].
In 2008, a comprehensive study was done correlating biochemical and genome wide expression levels in subjects from the three main Prakriti groups. There were many distinct differences in the regulation of genes in each of the main Prakriti groups. In Pitta types, for example, there was an over-expression of genes in the immune response pathways. In Vata males, there was an over-expression of genes related to cell cycles, particularly in the regulation of cyclin-dependent protein kinase activity and the regulation of enzyme activity. In Kapha males, there was a down-regulation of genes involved in fibrinolysis and an up-regulation of genes involved in ATP and cofactor biosynthesis. In addition, the researchers observed certain physiological differences such as Kapha types having higher levels of triglycerides, total cholesterol, high low-density lipoprotein (LDL) and low high-DL (HDL), compared to Pitta and Vata types. In Pitta types, they found hemoglobin and the red blood count were higher, whereas serum prolactin was higher in Vata types [3].
A study in 2010 studied high-altitude adaptation and common variations rs479200 (C/T) and rs480902 (T/C) in the EGLN1 gene. They found that the TT genotype of rs479200 was more frequent in Kapha types, and was correlated with a higher expression of EGLN1. In contrast, it was present at a significantly lower frequency in Pitta, and nearly absent in natives of high altitude. One of their interpretation is that Pitta types are more protected at high altitudes (see Table 1) [4].
Furthermore, a 2010 study showed that within Kapha types, there was a down-regulation of CYP2C19 genotypes, a family of genes that is involved in the detoxification and metabolism of certain drugs and an up-regulated in Pitta types [5]. In 2012, a paper appeared indicating that CD25 (activated B cells) and CD56 (natural killer cells) were higher in Kapha types [6].
A paper in 2012 studied rheumatoid arthritis patients and found that inflammatory genes were up-regulated in Vata types, while in Pitta and Kapha types there was an up-regulation of oxidative stress pathway genes [7]. In 2015, one of the most extensive and rigorous studies found that 52 SNPs (single nucleotide polymorphism) were significantly different in the three main types of Prakritis. Research also showed that the SNP (rs11208257) in PGM1 gene is correlated with energy production and is more homogenous and constant in Pitta than with Vata and Kapha types [8].
Another study done in 2015 identified DNA methylation signatures that distinguish the three major Prakriti types. The authors suggest that DNA methylation is probably coupled to chromatin regulation as a contributor to different Prakriti phenotypes, and that this research provides insight into the epigenetic mechanisms of the Ayurvedic personalized system of medicine [9].
One final paper in 2015 extended an earlier study, and found the combination of derived EGLN1 allele (HAPE associated) and ancestral VWF allele (thrombosis associated) was significantly high in the Kapha Prakriti group compared to the Pitta Prakriti group. They also showed a genetic link between EGLN1 and VWF, which could modify thrombosis/bleeding susceptibility and outcomes of hypoxia [10].

3. Studies on Physiology, Disease and Prakriti

A paper in 2003 showed that the Kapha Prakriti groups had a number of biochemical differences from Pittas or Vatas. They showed higher digoxin levels, increased glycoconjugate levels, increased free radical production and reduced scavenging, as well as increased tryptophan catabolites and reduced tyrosine catabolites [11]. In 2011, researchers found a significant decrease in the diastolic blood pressure immediately after isotonic exercise for five minutes in Vata-Kapha types, in contrast to Pitta-Kapha and Vata-Pitta types [12]. In another study, it was found that ADP-induced maximal platelet aggregation (MPA) was maximum among Vata-Pitta-type individuals [13].
Research reported in 2014 found a correlation between body mass index (BMI) and Prakriti type. It was reported that Kapha Prakriti subjects had a higher BMI than those with a Vata Prakriti [14]. A paper in 2015 found that Kapha types have higher parasympathetic activity and lower sympathetic activity in terms of cardiovascular reactivity, compared to Pitta or Vata types [15].
Several papers have also correlated disease conditions with Prakriti. A 2012 paper reported that Vata-Kapha types had significantly higher triglyceride, VLDL and LDL levels, as well as lower HDL cholesterol when compared with other constitution types. The researchers also found that Vata-Kapha Prakriti individuals had higher risk for diabetes mellitus, hypertension and dyslipidemia. In addition, Vata-Kapha types had higher levels of biochemical markers such as IL6, TNF alpha, hsCRP and HOMA IR. The Vata-Kapha and Kapha Prakriti groups were both correlated with higher levels of the inflammatory markers. The conclusion of the authors was that there is a high correlation of risk factors associated with the Vata-Kapha and Kapha Prakriti groups [16].
Another paper in 2012 looked at diabetic patients and studied the effects of walking (isotonic exercise). There was a significant decrease in systolic blood pressure in Vata-Pitta, Pitta-Kapha and Vata-Kapha types after walking. There was also a significant decrease in mean diastolic blood pressure in Vata-Pitta types [17]. Another paper found that the incidence of Parkinson’s disease was highest in patients with a Vata Prakriti [18]. In a 2015 study of patients with irritable bowel syndrome, it was found that most of the Vata type patients had developed IBS-C, or irritable bowel syndrome associated with constipation. The patients who were Pitta dominant developed IBS-D, or irritable bowel syndrome associated with diarrhea. The quality of life was found to be better in in Pitta-type patients [19]. Finally, several papers have focused on the connection between the microbiome composition and Prakriti, and found a significant correlation between specific bacteria groups and Prakriti [20,21,22].

4. Theoretical Papers

In addition to the research papers, there have been a number of theoretical and review papers. In 2008 and 2010, papers began promoting the idea of the connection between Ayurveda and genomics [23,24]. In 2011, a review and theoretical papers appeared in which the term Ayurgenomics was presented [25,26,27,28]. Since 2012, there have been many theoretical and review papers on Ayurgenomics from different angles [29,30,31,32,33,34,35,36,37,38,39,40,41]. In a few of these papers, the focus is also on related fields such as Pharmacogenetics and Ayurnutrigenomics [31,32]. In one 2016 paper, Ayurveda is described as an ancient science of epigenetics [42].

5. Modern Medicine and Ayurgenomics

Modern medicine uses a highly reductionist system to describe the fundamental basis of our physiology and health, using terms like genome, gene expression and epigenetics. Ayurveda uses an entirely different holistic system, which includes terms such as dosha and Prakriti.
Unfortunately, modern medicine has not recognized many of the useful preventative approaches of Ayurveda, due to a cognitive bias against folk or traditional medicine. Even though traditional systems of medicine are still widely used in many countries around the world, more research on their preventative and therapeutic treatment programs is necessary [43].
Up to now, the research has been primarily on specific herbal preparations, with the main outcome being an attempt to isolate one active ingredient which can then be used by a pharmaceutical company. Ayurgenomics offers a new bridge between traditional medicine and modern medicine by providing a rigorous scientific understanding of basic concepts, and at the same time incorporating the practical preventative approaches of Ayurveda into modern medicine.
Over the last ten years, a new field has arisen in modern medicine, which is known as P4 medicine. The four Ps are: predictive; preventive; personalized; and participatory [44,45,46,47]. This new system attempts to switch the emphasis from a disease-oriented system to a wellness-oriented system centered around the patient. It is closely related to other new fields such as Integrative Medicine, Functional Medicine, Lifestyle Medicine, Personalized Medicine and Preventive Medicine.
Ayurveda and other systems of traditional medicine have been patient-oriented and predictive, preventive, personalized and participatory for many thousands of years.
Long before the advent of epigenetic and other fields such as nutrigenetics, Ayurveda understood how diet and other lifestyle factors could affect our health. They recognized what modern medicine is only beginning to comprehend, that prevention is key to health. Improvements in diet, sleep, exercise and stress management are crucial for an effectively preventative system of medicine.
The development of Ayurgenomics, as we have said, helps give credibility to Ayurveda and other systems of traditional medicine by describing their ancient concepts in terms of modern science. New approaches in Ayurgenomics, which use big data analysis and machine learning, may greatly facilitate this whole process [36,37,39]. Of course, the therapeutic programs of these system will ultimately have to be tested through carefully controlled clinical trials.
Ayurveda and genomics can contribute to each other. Modern science can help Ayurveda as an evidence-based system of medicine, and Ayurveda can help modern medicine, particularly through its preventative approaches. This is especially true with P4 medicine, which is based on many of the same principles of Ayurveda. Having time-tested personalized preventative lifestyle recommendations would make it easy for each individual to participate in their own self-care (see Figure 1).
Ayurveda could also contribute to modern medicine in terms of the diagnosis of disease. Many believed that the enormous progress in the field of genomics would quickly bring a personalized system of medicine that could predict and prevent disease. Progress has been made, but researchers now realize that this may take longer than expected due to the highly complex nature of gene expression in the development of disease conditions. Ayurveda could help by stratifying individuals into broader categories using the Prakriti system of classification, along with modern genomics. Can we consider Prakriti as being our Ayurvedic genome? Can Ayurgenomics be used to diagnose and treat diseases?
These and many other questions will need to be answered by future research. We can only hope that a massive research effort is undertaken as soon as possible. The combination of Ayurveda and genomics promises to markedly improve many areas of healthcare throughout the world.


This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. A grant from the Wege Foundation helped pay for publication costs.


Thanks to Roxanne Medeiros for creating the graphic.

Conflicts of Interest

The author declares no conflict of interest.


  1. Dash, B.; Sharma, R.K. Charaka Samhita; Caukhambha Orientalia: Varanasi, India, 1995. [Google Scholar]
  2. Patwardhan, B.; Joshi, K.; Chopra, A. Classification of Human population based on HLA Gene Polymorphism and the Concept of Prakriti in Ayurveda. J. Altern. Complementary Med. 2005, 11, 349–353. [Google Scholar]
  3. Prasher, B.; Negi, S.; Aggarwal, S.; Mandal, A.K.; Sethi, T.P.; Deshmukh, S.R.; Purohit, S.G.; Sengupta, S.; Khanna, S.; Mohammad, F.; et al. Whole Genome Expression and Biochemical Correlates of Extreme Constitutional Types Defined in Ayurveda. J. Transl. Med. 2008, 6, 48. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Aggarwal, S.; Negi, S.; Jha, P.; Singh, P.K.; Stobdan, T.; Pasha, M.A. Indian genome variation consortium. EGLN1 involvement in high-altitude adaptation revealed through genetic analysis of extreme constitution types defined in Ayurveda. Proc. Natl. Acad. Sci. USA 2010, 107, 18961–18966. [Google Scholar] [CrossRef] [Green Version]
  5. Ghodke, Y.; Joshi, K.; Patwardhan, B. Traditional medicine to modern pharmacogenomics: Ayurveda Prakriti type and CYP2C19 gene polymorphism associated with the metabolic variability. Evid. Based Complementary Alternat. Med. 2011, 249528. [Google Scholar]
  6. Rotti, H.; Guruprasad, K.P.; Nayak, J.; Kabekkodu, S.P.; Kukreja, H.; Mallya, S.; Nayak, J.; Bhradwaj, R.C.; Gangadharan, G.G.; Prasanna, B.V.; et al. Immunophenotyping of normal individuals classified on the basis of human dosha prakriti. J. Ayurveda Integr. Med. 2014, 5, 43–49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Juyal, R.C.; Negi, S.; Wakhode, P.; Bhat, S.; Bhat, B.; Thelma, B.K. Potential of ayurgenomics approach in complex trait research: Leads from a pilot study on rheumatoid arthritis. PLoS ONE 2012, 7, e45752. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Govindaraj, P.; Nizamuddin, S.; Sharath, A.; Jyothi, V.; Rotti, H.; Raval, R.; Nayak, J.; Bhat, B.K.; Prasanna, B.V.; Shintre, P.; et al. Genome-wide analysis correlates Ayurveda Prakriti. Sci. Rep. 2015, 5, 15786. [Google Scholar] [CrossRef] [Green Version]
  9. Rotti, H.; Mallya, S.; Kabekkodu, S.P.; Chakrabarty, S.; Bhale, S.; Bharadwaj, R.; Bhat, B.K.; Dedge, A.P.; Dhumal, V.R.; Gangadharan, G.G.; et al. DNA methylation analysis of phenotype specific stratified Indian population. J. Transl. Med. 2015, 13, 151. [Google Scholar] [CrossRef] [Green Version]
  10. Aggarwal, S.; Gheware, A.; Agrawal, A.; Ghosh, S.; Prasher, B.; Mukerji, M.; Indian Genome Variation Consortium. Combined genetic effects of EGLN1 and VWF modulate thrombotic outcome in hypoxia revealed by Ayurgenomics approach. J. Transl. Med. 2015, 13, 184. [Google Scholar] [CrossRef] [Green Version]
  11. Kurup, R.K.; Kurup, P.A. Hypothalamic digoxin, hemispheric chemical dominance, and the tridosha theory. Int. J. Neurosci. 2003, 113, 657–681. [Google Scholar] [CrossRef]
  12. Tiwari, S.; Gehlot, S.; Tiwari, S.K.; Singh, G. Effect of walking (aerobic isotonic exercise) on physiological variants with special reference to Prameha (diabetes mellitus) as per Prakriti. Ayu 2012, 33, 44–49. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Bhalerao, S.; Deshpande, T.; Thatte, U. Prakriti (Ayurvedic concept of constitution) and variations in Platelet aggregation. BMC Complementary Altern. Med. 2012, 12, 248–256. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Rotti, H.; Raval, R.; Anchan, S.; Bellampalli, R.; Bhale, S.; Bharadwaj, R.; Bhat, B.K.; Dedge, A.P.; Dhumal, V.R.; Gangadharan, G.G.; et al. Determinants of prakriti, the human constitution types of Indian traditional medicine and its correlation with contemporary science. J. Ayurveda Integr. Med. 2014, 5, 167e75. [Google Scholar]
  15. Rapolu, S.B.; Kumar, M.; Singh, G.; Patwardhan, K. Physiological variations in the autonomic responses may be related to the constitutional types defined in Ayurveda. J. Humanitas Med. 2015, 5, e7. [Google Scholar] [CrossRef]
  16. Mahalle, N.P.; Kulkarni, M.V.; Pendse, N.M.; Naik, S.S. Association of constitutional type of Ayurveda with cardiovascular risk factors, inflammatory markers and insulin resistance. J. Ayurveda Integr. Med. 2012, 3, 150–157. [Google Scholar] [CrossRef] [Green Version]
  17. Tripathi, P.K.; Patwardhan, K.; Singh, G. The basic cardiovascular responses to postural changes, exercise and cold pressor test: Do they vary in accordance with the dual constitutional types of Ayurveda? Evid. Based Complementary Altern. Med. 2011, 201, 251–259. [Google Scholar] [CrossRef] [Green Version]
  18. Manyam, B.V.; Kumar, A. Ayurvedic constitution (prakruti) identifies risk factor of developing Parkinson’s disease. J. Altern. Complementary Med. 2013, 19, 644–649. [Google Scholar] [CrossRef]
  19. Shirolkar, S.G.; Tripathi, R.K.; Rege, N.N. Evaluation of prakṛti and quality-of-life in patients with irritable bowel syndrome. Ancient science of life. J. Altern. Complementary Med. 2015, 34, 210–215. [Google Scholar] [CrossRef]
  20. Chauhan, N.S.; Pandey, R.; Mondal, A.K.; Gupta, S.; Verma, M.K.; Jain, S.; Ahmed, V.; Patil, R.; Agarwal, D.; Girase, B.; et al. Western Indian Rural Gut Microbial Diversity in Extreme Prakriti Endo-Phenotypes Reveals Signature Microbes. Front. Microbiol. 2018, 9, 118. [Google Scholar] [CrossRef]
  21. Jnana, A.; Murali, T.S.; Guruprasad, K.P.; Satyamoorthy, K. Prakriti phenotypes as a stratifier of gut microbiome: A new frontier in personalized medicine? J. Ayurveda Integr. Med. 2020, 11, 360–365. [Google Scholar] [CrossRef]
  22. Wallace, R.K. The Microbiome in Health and Disease from the Perspective of Modern Medicine and Ayurveda. Medicina 2020, 56, 462. [Google Scholar] [CrossRef] [PubMed]
  23. Patwardhan, B.; Bodeker, G. Ayurvedic genomics: Establishing a genetic basis for mind-body typologies. J. Altern. Complementary Med. 2008, 14, 571–576. [Google Scholar] [CrossRef]
  24. Joshi, K.; Ghodke, Y.; Shintre, P. Traditional medicine and genomics. J. Ayurveda Integr. Med. 2010, 1, 26–32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Rizzo-Sierra, C.V. Ayurvedic genomics, constitutional psychology, and endocrinology: The missing connection. J. Altern. Complementary Med. 2011, 17, 465–468. [Google Scholar] [CrossRef] [PubMed]
  26. Chatterjee, B.; Pancholi, J. Prakriti-based medicine: A step towards personalized medicine. Ayu 2011, 32, 141–146. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Mukerji, M.; Prasher, B. Ayurgenomics: A New Approach in Personalized and Preventive Medicine. Sci. Cult. 2011, 77, 10–17. [Google Scholar]
  28. Sethi, T.P.; Prasher, B.; Mukerji, M. Ayurgenomics: A New Way of Threading Molecular Variability for Stratified Medicine. ACS Chem. Biol. 2011, 6, 875–880. [Google Scholar] [CrossRef]
  29. Nayak, J. Ayurveda research: Ontological challenges. J. Altern. Complementary Med. 2012, 3, 17–20. [Google Scholar] [CrossRef] [Green Version]
  30. Dey, S.; Pahwa, P. Prakriti and its associations with metabolism, chronic diseases, and genotypes: Possibilities of new born screening and a lifetime of personalized prevention. J. Ayurveda Integr. Med. 2014, 5, 15–24. [Google Scholar] [CrossRef]
  31. Gupta, P.D. Pharmacogenetics, pharmacogenomics and Ayurgenomics for personalized medicine: A paradigm shift. Indian J. Pharm. Sci. 2015, 77, 135–141. [Google Scholar] [CrossRef]
  32. Banerjee, S.; Debnath, P.; Debnath, P.K. Ayurnutrigenomics: Ayurveda-inspired personalized nutrition from inception to evidence. J. Tradit. Complementary Med. 2015, 5, 228–233. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Prasher, B.; Gibson, G.; Mukerji, M. Genomic insights into ayurvedic and western approaches to personalized medicine. J. Genet. 2016, 95, 209–228. [Google Scholar] [CrossRef] [PubMed]
  34. Mukerji, M.; Prasher, B. Genomics and traditional Indian ayurvedic medicine. In Genomics and Society: Ethical, Legal, Cultural and Socioeconomic Implications; Kumar, D., Chadwick, R., Eds.; Academic Press: Cambridge, MA, USA, 2016; pp. 271–292. [Google Scholar]
  35. Prasher, B.; Varma, B.; Kumar, A.; Khuntia, B.K.; Pandey, R.; Narang, A.; Tiwari, P.; Kutum, R.; Guin, D.; Kukreti, R.; et al. Ayurgenomics for stratified medicine: TRISUTRA consortium initiative across ethnically and geographically diverse Indian populations. J. Ethnopharmacol. 2017, 197, 274–293. [Google Scholar] [CrossRef] [PubMed]
  36. Mukerji, M.; Sagner, M. Genomics and Big Data Analytics in Ayurvedic Medicine. Prog. Prev. Med. 2019, 4, e0021. [Google Scholar] [CrossRef]
  37. Tiwari, P.; Kutum, R.; Sethi, T.; Shrivastava, A.; Girase, B.; Aggarwal, S.; Patil, R.; Agarwal, D.; Gautam, P.; Agrawal, A.; et al. Recapitulation of Ayurveda constitution types by machine learning of phenotypic traits. PLoS ONE 2017, 12, e0185380. [Google Scholar] [CrossRef]
  38. Jayasundar, R. If systems approach is the way forward, what can the Ayurvedic theory of Tridosha teach us? Curr. Sci. 2017, 112. [Google Scholar] [CrossRef]
  39. Singh, H.; Bhargava, S.; Ganeshan, S.; Kaur, R.; Sethi, T.; Sharma, M.; Chauhan, M.; Chauhan, N.; Chauhan, R.; Chauhan, P.; et al. Big Data Analysis of Traditional Knowledge-based Ayurveda Medicine. Prog. Prev. Med. 2018, 3, e0020. [Google Scholar] [CrossRef]
  40. Dhande, S.; Salunkhe, P. Ayurgenomics. Inter. J. Res. Sci. Innov. 2018, V, 322–326. [Google Scholar]
  41. Singh, S.; Gehlot, S.; Agrawal, N.K. Basis of Disease Manifestation: A Molecular and Ayurvedic Approach with an Integrated Concept of Ayurgenomics. J. Nat. Remedies 2019, 19. [Google Scholar] [CrossRef]
  42. Sharma, H. Ayurveda: Science of life, genetics, and epigenetics. Ayu 2016, 37, 87–91. [Google Scholar] [CrossRef]
  43. Lemonnier, N.; Zhou, G.B.; Prasher, B.; Mukerji, M.; Chen, Z.; Brahmachari, S.K.; Noble, D.; Auffray, C.; Sagner, M. Traditional knowledge-basedmedicine: A review of history, principles, and relevance in the present context of P4 systems medicine. Prog. Prev. Med. 2017, 7, e0011. [Google Scholar] [CrossRef]
  44. Hood, L.; Heath, J.R.; Phelps, M.E.; Lin, B. Systems biology and new technologies enable predictive and preventative medicine. Science 2004, 306, 640–643. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Weston, A.D.; Hood, L. Systems biology, proteomics, and the future of healthcare: Toward predictive, preventative, and personalized medicine. J. Proteome Res. 2004, 3, 179–196. [Google Scholar] [CrossRef] [PubMed]
  46. Hood, L.; Balling, R.; Auffray, C. Revolutionizing medicine in the 21st century through systems approaches. Biotechnol. J. 2012, 7, 992–1001. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Flores, M.; Glusman, G.; Brogaard, K.; Price, N.D.; Hood, L. P4 medicine: How systems medicine will transform the healthcare sector and society. Pers. Med. 2013, 10, 565–576. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Ayurgenomics and its Relationship to Modern Medicine.
Figure 1. Ayurgenomics and its Relationship to Modern Medicine.
Medicina 56 00661 g001
Table 1. Example of Prakriti and gene expression.
Table 1. Example of Prakriti and gene expression.
Prakriti TypeGene ExpressionDisease
Kapha/VataEGLN 1 higherHigh Altitude Pulmonary Edema
PittaEGLN 1 lowermore adaptive for higher altitudes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wallace, R.K. Ayurgenomics and Modern Medicine. Medicina 2020, 56, 661.

AMA Style

Wallace RK. Ayurgenomics and Modern Medicine. Medicina. 2020; 56(12):661.

Chicago/Turabian Style

Wallace, Robert Keith. 2020. "Ayurgenomics and Modern Medicine" Medicina 56, no. 12: 661.

Article Metrics

Back to TopTop